三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
BTLA联用特瑞普利单抗治疗对比
BTLA联用特瑞普利单抗治疗对比
其它
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:859KB
图片尺寸:1671*1240
同报告图片
/
4
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
所属报告:
君实生物-公司深度报告:国际一流团队加盟助力公司全面提升特瑞普利为矛出海迎来新起点-231215(54页).pdf
打包全文图表
相关数据
度普利尤单抗(达必妥)全球销售额(2017-2025年)
fCDlubTku70gfCDnvo7lm73vvIjnmb7kuIfmrKflhYPvvIkgfCDmrKfmtLLvvIjnmb7kuIfmrKflhYPvvIkgfCDlhbbku5blm73lrrblkozlnLDljLrvvIjnmb7kuIfmrKflhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IDIwMTcgfCAyMDAgICAgICAgICAgICAgIHwgNTAgICAgICAgICAgICAgICB8IDUwICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMTggfCA4MDAgICAgICAgICAgICAgIHwgMTAwICAgICAgICAgICAgICB8IDEwMCAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMTkgfCAxODAwICAgICAgICAgICAgIHwgMTUwICAgICAgICAgICAgICB8IDE1MCAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjAgfCAyODAwICAgICAgICAgICAgIHwgMjAwICAgICAgICAgICAgICB8IDIwMCAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjEgfCA0MDAwICAgICAgICAgICAgIHwgNTAwICAgICAgICAgICAgICB8IDUwMCAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjIgfCA2NTAwICAgICAgICAgICAgIHwgNzAwICAgICAgICAgICAgICB8IDgwMCAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjMgfCA4MjAwICAgICAgICAgICAgIHwgOTAwICAgICAgICAgICAgICB8IDEyMDAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjQgfCAxMDIwMCAgICAgICAgICAgIHwgMTEwMCAgICAgICAgICAgICB8IDE3MDAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjUgfCAxMTcwMCAgICAgICAgICAgIHwgMTQwMCAgICAgICAgICAgICB8IDI5MDAgICAgICAgICAgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya6LWb6K+66I+y5a2j5oql77yM55Sz5LiH5a6P5rqQ56CU56m2
收藏
行业数据
2026-05-28
原图定位
查看详情
度普利尤单抗2024年销售额超140亿美元,持续快速放量中
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
收藏
行业数据
2025-12-26
原图定位
查看详情
截至2025年9月底,度普利尤单抗、司普奇拜单抗分别获批8项、3项适应症,且适应症持续拓展
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
收藏
行业数据
2025-12-26
原图定位
查看详情
度普利尤单抗全球范围销售收入
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
收藏
行业数据
2025-11-21
原图定位
查看详情
特瑞普利单抗获国际权威指南认证助推海外放量
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
收藏
行业数据
2025-10-24
原图定位
查看详情
度普利尤单抗销售额2024年超140亿美元,仍呈现快速增长态势
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
收藏
行业数据
2025-09-17
原图定位
查看详情
度普利尤单抗销售额2024年超140亿美元,仍呈现快速增长态势
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
收藏
行业数据
2025-09-17
原图定位
查看详情
611治疗特异性皮炎的EASI75及NRS优于度普利尤单抗(II期数据)
fCBDb21wYW55IHwgSW5kaWNhdGlvbiB8IENvZGUgfAp8IC0tLSB8IC0tLSB8IC0tLSB8CnwgQSB8IEFEIGFwcHJvdmVkIHwgIHwKfCBCIHwgQXN0aG1hIE5EQSByZXZpZXdpbmcgfCAgfAp8IDNTQmlvIHwgQXN0aG1hIFBoYXNlIElJIGNvbXBsZXRlZCB8ICB8CnwgIHwgQUQgUGhhc2UgSUlJIHwgIHwKfCAgfCBDUlN3TlAgUGhhc2UgSUlJIHwgIHwKfCAgfCBDT1BEIFBoYXNlIElJIHwgIHwKfCAgfCBTU0dKLTYxMSB8ICB8CgrotYTmlpnmnaXmupDvvJrkuInnlJ/liLboja/lhazlj7jlrpjnvZHvvIzlm73nm5vor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2025-03-24
原图定位
查看详情
2017-2023年度普利尤单抗全球销售额(亿美元)
fCDlubTku70gfCDplIDllK7pop3vvIjkur/nvo7lhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18CnwgMjAxNyB8IDIuNDcgICAgICAgICAgIHwKfCAyMDE4IHwgOS4zMSAgICAgICAgICAgfAp8IDIwMTkgfCAyMy4zICAgICAgICAgICB8CnwgMjAyMCB8IDM5LjA3ICAgICAgICAgIHwKfCAyMDIxIHwgNjQuMSAgICAgICAgICAgfAp8IDIwMjIgfCA5NC4yOCAgICAgICAgICB8CnwgMjAyMyB8IDExNC42MyAgICAgICAgIHwKCui1hOaWmeadpea6kO+8mui1m+ivuuiPsuWumOe9keOAgeS4nOWMl+ivgeWIuA==
收藏
行业数据
2025-02-24
原图定位
查看详情
图17.度普利尤单抗的不良反应发生率整体与安慰剂类似
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
收藏
行业数据
2025-02-17
原图定位
查看详情
利妥昔单抗实际降幅平均值相对温和,依那西普因上市时间早竞争格局相对充分,集采降幅整体较大
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
收藏
竞争格局
2025-02-06
原图定位
查看详情
CM310临床疗效整体优于度普利尤单抗(非头对头)
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
收藏
行业数据
2024-12-27
原图定位
查看详情
2021Q3-2024Q3度普利尤单抗全球销售额(百万美元)
fCDml7bpl7QgICAgICAgfCBVU+mUgOWUrumine+8iOeZvuS4h+e+juWFg++8iSB8IOe+juWbveWklumUgOWUrumine+8iOeZvuS4h+e+juWFg++8iSB8IOaAu+mUgOWUrumine+8iOeZvuS4h+e+juWFg++8iSB8CnwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDIx5bm056ys5LiJ5a2j5bqmIHwgMSwwNjEgICAgICAgICAgICAgICAgfCAzNDkgICAgICAgICAgICAgICAgICAgICB8IDEsNDEwICAgICAgICAgICAgICAgfAp8IDIwMjLlubTnrKzkuInlraPluqYgfCAxLDgwMyAgICAgICAgICAgICAgICB8IDUxMSAgICAgICAgICAgICAgICAgICAgIHwgMiwzMTQgICAgICAgICAgICAgICB8CnwgMjAyM+W5tOesrOS4ieWto+W6piB8IDIsMTY0ICAgICAgICAgICAgICAgIHwgNjg0ICAgICAgICAgICAgICAgICAgICAgfCAyLDg0NyAgICAgICAgICAgICAgIHwKfCAyMDI05bm056ys5LiJ5a2j5bqmIHwgMiw1NTYgICAgICAgICAgICAgICAgfCA5MjAgICAgICAgICAgICAgICAgICAgICB8IDMsNDc2ICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya6LWb6K+66I+yMjAyNOW5tOS4ieWto+aKpe+8jOa1meWVhuivgeWIuOeglOeptuaJgA==
收藏
行业数据
2024-12-27
原图定位
查看详情
2020-2023年度普利尤单抗国内样本医院销售额
fCDlubTku70gfCDljLvpmaLvvIjkur/lhYPvvIkgfCDoja/lupfvvIjkur/lhYPvvIkgfCDlop7plb/njofvvIgl77yJIHwKfC0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCAyMDIw5bm0IHwgMSB8IDAgfCAtIHwKfCAyMDIx5bm0IHwgMyB8IDIgfCAtIHwKfCAyMDIy5bm0IHwgOSB8IDQgfCAtIHwKfCAyMDIz5bm0IHwgMTQgfCA2IHwgLSB8CnwgMjAyNEgxIHwgOSB8IDMgfCAtIHwKCui1hOaWmeadpea6kO+8muexs+WGhee9ke+8iOagt+acrOWMu+iNr+WPiuiNr+W6l+aUvuWkp+aVsOaNru+8ie+8jOa1meWVhuivgeWIuOeglOeptuaJgA==
收藏
行业数据
2024-12-27
原图定位
查看详情
阿布昔替尼的应答率及应答时间优于度普利尤单抗
fCBXZWVrcyB8IFBsYWNlYm8gfCBBYnJvY2l0aW5pYiwgMTAwIG1nIHwgQWJyb2NpdGluaWIsIDIwMCBtZyB8IER1cGlsdW1hYiwgMzAwIG1nIHwKfC0tLS0tLS18LS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyICAgICB8IDYuMSAgICAgfCAxNC4wICAgICAgICAgICAgICAgIHwgMTYuMCAgICAgICAgICAgICAgICB8IDguMyAgICAgICAgICAgICAgIHwKfCA0ICAgICB8IDguMyAgICAgfCAyMi4wICAgICAgICAgICAgICAgIHwgMjguMCAgICAgICAgICAgICAgICB8IDE2LjcgICAgICAgICAgICAgIHwKfCA4ICAgICB8IDEwLjcgICAgfCAzNi42ICAgICAgICAgICAgICAgIHwgNDguNCAgICAgICAgICAgICAgICB8IDM2LjUgICAgICAgICAgICAgIHwKfCAxMiAgICB8IDEyLjkgICAgfCAzNC44ICAgICAgICAgICAgICAgIHwgNDcuNSAgICAgICAgICAgICAgICB8IDM4LjggICAgICAgICAgICAgIHwKfCAxNiAgICB8IDE0LjUgICAgfCAzOC44ICAgICAgICAgICAgICAgIHwgNDguNCAgICAgICAgICAgICAgICB8IDQ3LjUgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8mkJpZWJlciBULCBBYnJvY2l0aW5pYiB2ZXJzdXMgUGxhY2VibyBvciBEdXBpbHVtYWIgZm9yIEF0b3BpYyBEZXJtYXRpdGlzLiBOIEVuZ2wgSiBNZWQu
收藏
行业数据
2024-12-12
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
今年 6 月,该联合疗法针对上述局限期小细胞肺癌(LS-SCLC)适应症的 3 期试验已经获得美国 FDA 和 NMPA 批准。针对难治性广泛期小细胞肺癌(ES-SCLC)的数据在 2023ASCO 年会上首次公布,I-O 初治患者缓解率达 40%。
其它
原图定位
当前图表所属:
君实生物-公司深度报告:国际一流团队加盟助力公司全面提升特瑞普利为矛出海迎来新起点-231215(54页).pdf
君实生物生产基地布局
君实生物研发中心
特瑞普利国内NDA适应症
君实产品销售额预测(2023-2025年)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》